Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
ID: 350787Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/350787

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-293.html
Timeline
    Description

    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) inviting applications for research on the ethical, legal, and social implications (ELSI) of human genetics and genomics. This initiative aims to support multidisciplinary research that engages diverse stakeholders and addresses systemic issues related to genomic research and healthcare equity, with a specific requirement for a Plan for Enhancing Diverse Perspectives (PEDP) as part of the application. The research is intended to improve understanding of genetic research implications across various populations, focusing on public health issues such as cancer disparities and mental health. Applications will be accepted starting January 19, 2024, with a project period of up to five years, and interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-23-293.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-293-Full-Announcement.html
    PAR-23-293.html
    The Department of Health and Human Services, through the NIH, has released a Notice of Funding Opportunity (NOFO) inviting applications for research on the ethical, legal, and social implications (ELSI) of human genetic and genomic advancements. This initiative encourages multidisciplinary approaches involving diverse stakeholders, emphasizing the importance of community engagement. The funding opportunities target various NIH institutes, fostering inclusivity in research via the required Plan for Enhancing Diverse Perspectives (PEDP). Key dates include an opening date for application submissions on January 19, 2024, with a proposal project period extending to a maximum of five years. The application process entails strict adherence to NIH guidelines, including a comprehensive data management and sharing plan. The overarching goal is to support research that improves understanding of genetic research implications across diverse populations, addressing historical inequities and fostering ethical genomic practices. Topics of interest span various public health issues, including but not limited to cancer disparities, mental health implications, and genomic healthcare integration. This NOFO aims to harness scientific innovation by engaging diverse perspectives and addressing systemic issues related to genomic research and healthcare equity.
    Similar Opportunities
    Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the "Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)" grant, aimed at investigating the ethical, legal, and social implications arising from human genetics and genomics research. Applicants are encouraged to utilize diverse multidisciplinary approaches, including empirical qualitative and quantitative methods, and must include a "Plan for Enhancing Diverse Perspectives" to promote inclusivity within research teams. This funding opportunity is critical for addressing complex issues related to genomic advancements, such as equity in healthcare and the implications of genomic data sharing. Applications will be accepted from January 2025 until November 18, 2026, with a maximum project period of five years, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for Exploratory/Developmental Research Grants (R21) focused on the Ethical, Legal, and Social Implications (ELSI) of human genetics and genomics. This initiative invites applications that utilize various methodologies, including qualitative and quantitative research, to explore ELSI issues and foster interdisciplinary collaboration while informing policy on equitable genomic research applications across diverse populations. The program aims to address critical areas such as cancer disparities and community engagement in genomics, recognizing the transformative potential of genomics in healthcare while assessing ethical and social challenges, particularly for underrepresented communities. Applicants may request up to $275,000 for projects lasting up to three years, with applications due between January 20, 2025, and November 19, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03), aimed at funding small-scale research projects that investigate the ethical, legal, and social dimensions of human genetics and genomics. This funding opportunity encourages innovative research that addresses the complexities and emerging questions associated with genomic advancements, particularly focusing on diverse populations and potential inequities in access and benefits. Eligible applicants include a wide range of entities such as higher education institutions, non-profits, and government agencies, with funding of up to $50,000 available per year for a maximum of two years. Applications will be accepted starting January 19, 2024, with various submission deadlines through 2026, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity" (RFA-HG-23-017), aimed at promoting health equity through innovative genomic research. This initiative encourages applicants to propose research that enhances the understanding and application of genomics across diverse U.S. populations, with a particular focus on engaging underrepresented groups and incorporating a Plan for Enhancing Diverse Perspectives (PEDP). The NIH plans to commit significant funds, with a maximum budget of $500,000 in direct costs per year for projects lasting four to five years, and applications are due by July 8, 2025. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to review the full announcement at NIH Grants.
    Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the "Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)" to support research that investigates the ethical, legal, and social implications of human genetics and genomics. This grant encourages applications that utilize a variety of research methods, including empirical qualitative and quantitative approaches, to address significant ELSI issues arising from advancements in genomic technologies. The initiative aims to foster community engagement, particularly with historically underserved populations in genomic research, reflecting a commitment to ethical considerations in scientific progress. Grants of up to $275,000 are available for projects spanning two to three years, with application deadlines starting January 19, 2024, and funding decisions expected by July 2024. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the Ethical, Legal, and Social Implications (ELSI) Small Research Grant (R03), aimed at supporting research on the implications of human genetics and genomics. This grant encourages applications that explore ELSI issues through various methodologies, including conceptual analyses and empirical studies, with an emphasis on community engagement and stakeholder involvement. The initiative seeks to enhance understanding of the societal impacts of genomic research, promote equitable healthcare access, and address disparities in genomic applications. Eligible applicants can receive up to $50,000 annually for a maximum of two years, with the application deadline set for November 16, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-370.html.
    Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1), Clinical Trial Optional
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program," aimed at fostering transdisciplinary ELSI research among underrepresented domestic organizations. The program seeks applications from entities that have received less than $30 million in NIH funding annually over the past three years, focusing on enhancing community engagement, building research capacity, and developing a diverse workforce in the field of genomics. With an anticipated funding amount of approximately $4.8 million for up to four awards, projects can last up to five years, and applicants must adhere to specific guidelines and deadlines, with submissions due by August 2, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) titled "Developing Novel Theory and Methods for Understanding the Genetic Architecture of Complex Human Traits" (PAR-25-255). This initiative aims to support interdisciplinary research that enhances the understanding of how genetic and non-genetic factors contribute to complex human traits, encouraging applicants to develop innovative theories and models while utilizing large-scale publicly accessible datasets. The funding opportunity is not open to clinical trials and allows for applications of up to five years, with a focus on rigorous scientific design and inclusivity through a Plan for Enhancing Diverse Perspectives (PEDP). Interested applicants should note that the open submission date begins on January 5, 2025, with various deadlines extending through 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)" aimed at supporting small-scale research projects that enhance health equity through genomic research. The initiative seeks to develop innovative approaches and metrics to ensure the equitable application of genomics in improving health outcomes for U.S. populations, particularly focusing on historically underrepresented groups in biomedical research. Eligible applicants include a wide range of organizations, such as higher education institutions, nonprofit organizations, and state governments, with funding available up to $200,000 annually for a maximum of two years. Interested parties should submit their applications by July 8, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage for more details at https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-23-018.html.
    Notice of Intent to Publish a Funding Opportunity Announcement for Transforming NHGRI�s Diversity Action Plan (R25 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a Funding Opportunity Announcement (FOA) aimed at transforming the National Human Genome Research Institute's (NHGRI) Diversity Action Plan (R25 Clinical Trials Not Allowed) to enhance workforce diversity in genomics. This initiative seeks to support the training, employment, and retention of individuals from underrepresented backgrounds in the biomedical workforce, aligning with NHGRI's strategic objectives to foster diverse scientific teams that drive innovation and creativity. The FOA is expected to be published in Summer 2023, with applications due in Early 2024, and the estimated award date is set for September 9, 2024. For further inquiries, interested parties can contact Dr. Lucia A. Hindorff at hindorffl@mail.nih.gov.